デジタルパソロジー市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

デジタルパソロジーの世界市場規模は、2024年に11億6,000万米ドルとなり、2030年までのCAGRは11.46%で、予測期間には22億3,000万米ドルに達すると予測されています。

デジタルパソロジーは、デジタル化された標本スライドからデータを抽出することに焦点を当てた専門分野です。デジタルパソロジーは、コンピュータベースの技術とバーチャル顕微鏡を活用することで、画像ベースの情報取得を可能にします。この革新的なアプローチは、世界中の病理検査室の効率、ワークフロー、収益を大幅に向上させています。ガラススライドをデジタル化することで、ユーザーはコンピュータのモニター上で簡単に管理、共有、閲覧、分析を行うことができます。デジタルパソロジーは、1次疾患診断、診断決定支援、術中診断、診断コンサルテーション、研修医および医学トレーニング、ピアレビュー、マニュアルおよび半定量免疫組織化学（IHC）レビュー、臨床調査など、さまざまな分野で応用されています。その導入は、検査室の効率改善と診断結果の迅速化につながっています。教育分野、医薬品開発、組織ベースの研究、疾病診断などからの支持が高まる中、デジタルパソロジーは、ヘルスケア分野で不可欠かつ実績のある技術として急速に認知されつつあります。

慢性疾患の負担増と、正確でタイムリーな診断に対する需要の高まりが、デジタルパソロジーの採用を促進する主な要因となっています。がん、心血管疾患、感染症の世界の罹患率が上昇を続ける中、ヘルスケアプロバイダーは診断を合理化し、精度を向上させる先進技術を求めています。デジタルパソロジーは高解像度の画像解析をサポートし、リモートアクセスによるセカンドオピニオンを容易にします。この機能は、診断精度を向上させるだけでなく、所要時間を短縮し、特に複雑な症例や重要な症例において、より迅速な臨床的意思決定と患者転帰の改善を可能にします。

市場促進要因

ラボの効率化

主な市場課題

高コストのデジタルパソロジー

主要市場動向

遠隔病理検査と遠隔診察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のデジタルパソロジー市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（スキャナー、ソフトウェア、ストレージおよび通信システム）
  • 用途別（疾患診断、遠隔診療、創薬、研修・教育）
  • エンドユーザー別（製薬・バイオテクノロジー企業、病院・診療所、学術機関・調査機関）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のデジタルパソロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のデジタルパソロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のデジタルパソロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のデジタルパソロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのデジタルパソロジー市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収

第13章 世界のデジタルパソロジー市場：SWOT分析

第14章 競合情勢

• 3DHISTECH.
• Corista
• Aiforia Technologies Oy
• Akoya Biosciences
• OptraSCAN
• Glencoe Software
• QProscia Inc
• Kanteron Systems
• Mikroscan Technologies

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Digital Pathology Market was valued at USD 1.16 billion in 2024 and is expected to reach USD 2.23 billion in the forecast period with a CAGR of 11.46% through 2030. Digital pathology is a specialized field that focuses on extracting data from digitized specimen slides. By utilizing computer-based technology and virtual microscopy, digital pathology enables the acquisition of image-based information. This innovative approach has significantly enhanced the efficiency, workflow, and revenue of pathology labs worldwide. Through the conversion of glass slides into digital counterparts, users can effortlessly manage, share, view, and analyze them on a computer monitor. Digital pathology finds applications in various areas, including primary disease diagnosis, diagnostic decision support, intraoperative diagnosis, diagnostic consultation, resident and medical training, peer review, manual and semi-quantitative immunohistochemistry (IHC) review, and clinical research. Its implementation has led to improved laboratory efficiency and faster diagnostic results. With growing support from the education sector, drug development, tissue-based research, and disease diagnosis, digital pathology is rapidly gaining recognition as an essential and proven technology in the healthcare sector.

The increasing burden of chronic diseases and the growing demand for precise and timely diagnostics are major factors driving the adoption of digital pathology. As the global incidence of cancer, cardiovascular conditions, and infectious diseases continues to rise, healthcare providers are seeking advanced technologies that streamline diagnosis and improve accuracy. Digital pathology supports high-resolution image analysis and facilitates second opinions through remote access, which is particularly beneficial in underserved and rural regions. This capability not only enhances diagnostic accuracy but also reduces turnaround times, enabling faster clinical decision-making and better patient outcomes, especially in complex or critical cases.

Key Market Drivers

Enhanced Lab Efficiency

Digital pathology dramatically improves laboratory efficiency by accelerating image analysis and report turnaround. Recent data shows that slide review times have decreased by up to 40% after digital adoption, allowing pathologists to process more cases daily. Additionally, remote consultation speeds have improved by 50%, as specialists can collaborate in real time without physical slides. These efficiency gains not only alleviate workload but also shorten patient wait times for critical diagnostic results. With quicker access to digital slides, labs can streamline workflows, reduce bottlenecks, and improve overall operational performance in both clinical and research settings.

By enabling remote access to pathology images, digital platforms foster seamless collaboration among healthcare professionals. Specialists can review cases and consult across geographic locations instantly, eliminating delays tied to shipping and physical slide transfer. Studies show that 75% of pathologists report enhanced diagnostic confidence through virtual peer reviews. This collaborative environment promotes accurate diagnoses and accelerates treatment decisions-ultimately improving patient outcomes. As cross-functional teams, including oncologists and geneticists, access slides simultaneously, multidisciplinary care coordination is significantly enhanced, reinforcing the growing need for digital pathology in modern healthcare systems.

Another major advantage is cost reduction. Digital pathology eliminates phased costs associated with producing, storing, and transporting glass slides. For example, laboratories have reported up to 60% savings on shipping and archiving expenses. Storage facilities that once required extensive physical archive space are now replaced by secure digital repositories, reducing overhead. Additionally, digital retrieval systems enable rapid, on-demand access to historical slides, supporting longitudinal studies and clinical audits. This shift toward digital archives reduces operational complexity, enhances data integrity, and cuts total ownership costs-strengthening the case for digital investments.

Key Market Challenges

High Cost of Digital Pathology

The high cost of digital pathology and the low adoption rate in emerging and underdeveloped countries present obstacles to the market's growth. Augmenting addresses this challenge by offering a modular hardware platform with integrated digital pathology software applications, helping to keep costs low. Implementing digital pathology systems requires significant upfront investment in scanners, storage infrastructure, and software solutions. The expenses associated with digitizing slides, maintaining digital archives, and training personnel can be substantial, especially for small laboratories or healthcare facilities with limited budgets. Furthermore, integrating digital pathology into existing laboratory workflows and the need for IT support and infrastructure upgrades can pose challenges for some organizations.

Key Market Trends

Telepathology and Remote Consultation

The increasing adoption of telepathology enables remote diagnosis and consultation, allowing pathologists to collaborate and provide expert opinions without being limited by geographical constraints. Telepathology has gained significant prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For instance, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or offer consultations to underserved areas or regions facing a shortage of pathology expertise. The increasing preference for computer-aided diagnosis, integrating image processing, physics, mathematics, and computing algorithms, facilitates efficient disease detection. It also assists in evaluating anatomic structures of interest, quantifying disease progression and risk assessment, thereby stimulating market growth. Notably, companies like Olympus offer a range of tools for remote slide sharing and image processing, contributing to anticipated market expansion in the upcoming years. In April 2020, Leica Biosystems obtained FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer, enabling remote diagnosis during the pandemic. Additionally, during this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution, further supporting remote diagnosis.

Key Market Players

• 3DHISTECH
• Corista
• Aiforia Technologies Oy
• Akoya Biosciences
• OptraSCAN
• Glencoe Software
• QProscia Inc
• Kanteron Systems
• Mikroscan Technologies

Report Scope:

In this report, the Global Digital Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Pathology Market, By Product Type:

• Scanners
• Software
• Storage & Communication Systems

Digital Pathology Market, By Application:

• Disease Diagnosis
• Teleconsultation
• Drug Discovery
• Training & Education

Digital Pathology Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals and Clinics
• Academics Institutes & Research Laboratories

Digital Pathology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pathology Market.

Available Customizations:

Global Digital Pathology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Pathology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Scanners, Software, and Storage & Communication Systems)
  • 5.2.2. By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education)
  • 5.2.3. By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Digital Pathology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Pathology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Digital Pathology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Digital Pathology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Digital Pathology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Pathology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Digital Pathology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Digital Pathology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Digital Pathology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Digital Pathology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Digital Pathology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Digital Pathology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Digital Pathology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Digital Pathology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Digital Pathology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Digital Pathology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Digital Pathology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Digital Pathology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Digital Pathology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Digital Pathology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Digital Pathology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Digital Pathology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Digital Pathology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Digital Pathology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions

13. Global Digital Pathology Market: SWOT Analysis

14. Competitive Landscape

• 14.1. 3DHISTECH.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Corista
• 14.3. Aiforia Technologies Oy
• 14.4. Akoya Biosciences
• 14.5. OptraSCAN
• 14.6. Glencoe Software
• 14.7. QProscia Inc
• 14.8. Kanteron Systems
• 14.9. Mikroscan Technologies

15. Strategic Recommendations

16. About Us & Disclaimer